## Objective: To examine demographic and disease-related variables that affect pain in a large cohort of patients with juvenile rheumatoid arthritis (jra). ## Methods: Selection criteria were an onset of jra >/=5 years prior to study and age >/=8 years at the time of the study. pain was measured
Measurement of health status in children with juvenile rheumatoid arthritis
โ Scribed by Gurkirpal Singh; Balu H. Athreya; James F. Fries; Donald P. Goldsmith
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 705 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
โฆ Synopsis
Objective. To develop and validate a self-or parent-administered instrument for measuring functional status in children with juvenile rheumatoid arthritis (JRA).
Methods. We adapted the Stanford Health Assessment Questionnaire (HAQ) for use in children ages 1-19 years, by adding several new questions, such that for each functional area, there was at least 1 question relevant to children of all ages. The face validity of the instrument was evaluated by a group of 20 health professionals and parents of 22 healthy children. The questionnaire was then administered to parents of 72 JRA patients (mean age 9.1 years, onset type systemic in 16, polyarticular in 21, pauciarticular in 35). Results. The instrument showed excellent internal reliability (Cronbach's a = 0.94), with a mean inter-item correlation of 0.6. The convergent validity was demonstrated by strong correlations of the Disability Index (average of scores on all functional areas) with Steinbrocker functional class (Kendall's tau b = 0.77, P < O.OOOl), number of involved joints (Kendall's tau b = 0.67, P < O.OOOl), and morning stiffness (Kendall's tau b = 0.54, P < 0.0001). Spearman's correlation coefficient between Disability Index scores from questionnaires administered to parents and those from questionnaires administered to older children (>8 years) was 0.84 (n = 29; P < 0.001), showing that parents can accurately report for their children. The test-retest
๐ SIMILAR VOLUMES
Twenty-three children with destructive polyarticular juvenile rheumatoid arthritis (JRA) were treated for 0 . 5 4 3 years (median 1.6 years) with weekly doses of methotrexate (MTX) (0.11-0.6 mg/kg/week). Serum levels of MTX at 1 hour and at 24 hours after drug administration were obtained at each do